These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26417848)
1. Effects of baffle configuration and tank size on spherical agglomerates of dimethyl fumarate in a common stirred tank. Lin PY; Lee HL; Chen CW; Lee T Int J Pharm; 2015 Nov; 495(2):886-94. PubMed ID: 26417848 [TBL] [Abstract][Full Text] [Related]
4. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation. Mašić I; Ilić I; Dreu R; Ibrić S; Parojčić J; Durić Z Int J Pharm; 2012 Feb; 423(2):202-12. PubMed ID: 22197773 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles. Han X; Ghoroi C; To D; Chen Y; Davé R Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954 [TBL] [Abstract][Full Text] [Related]
6. On the mechanisms of formation of spherical agglomerates. Thati J; Rasmuson AC Eur J Pharm Sci; 2011 Mar; 42(4):365-79. PubMed ID: 21216285 [TBL] [Abstract][Full Text] [Related]
7. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique. Maghsoodi M Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281 [TBL] [Abstract][Full Text] [Related]
8. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924 [TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix. Jadhav N; Pawar A; Paradkar A AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809 [TBL] [Abstract][Full Text] [Related]
10. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method. Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016 [TBL] [Abstract][Full Text] [Related]
11. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement. Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415 [TBL] [Abstract][Full Text] [Related]
13. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique. Pawar A; Paradkar A; Kadam S; Mahadik K AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization. Maghsoodi M; Tajalli Bakhsh AS Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665 [TBL] [Abstract][Full Text] [Related]
15. Effect of a melt agglomeration process on agglomerates containing solid dispersions. Vilhelmsen T; Eliasen H; Schaefer T Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973 [TBL] [Abstract][Full Text] [Related]
16. Improved processability of ethambutol hydrochloride by spherical agglomeration. Nitsure A; Patel D; Wairkar S Pharm Dev Technol; 2020 Mar; 25(3):376-384. PubMed ID: 31842656 [TBL] [Abstract][Full Text] [Related]
17. Shear-induced APAP de-agglomeration. Llusa M; Levin M; Snee RD; Muzzio FJ Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208 [TBL] [Abstract][Full Text] [Related]
18. Spherical crystallization of benzoic acid. Katta J; Rasmuson AC Int J Pharm; 2008 Feb; 348(1-2):61-9. PubMed ID: 17765414 [TBL] [Abstract][Full Text] [Related]
19. Effect of particle properties on the flowability of ibuprofen powders. Liu LX; Marziano I; Bentham AC; Litster JD; White ET; Howes T Int J Pharm; 2008 Oct; 362(1-2):109-17. PubMed ID: 18652883 [TBL] [Abstract][Full Text] [Related]
20. Characterization of an active pharmaceutical ingredient by its dissolution properties: amoxicillin trihydrate as a model drug. Horkovics-Kovats S Chemotherapy; 2004 Nov; 50(5):234-44. PubMed ID: 15528889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]